Please login to the form below

EU

This page shows the latest EU news and features for those working in and with pharma, biotech and healthcare.

AZ raises full-year guidance after completing Alexion acquisition in Q2

This includes the company’s complement component 5 (C5) inhibitors Soliris (eculizumab) and Ultomiris (ravulizumab), which are already available in the US and EU.

Latest news

AZ’s PNH therapy Ultomiris wins EU backing to expand use for children

This includes the company’s complement component 5 (C5) inhibitors Soliris and Ultomiris, which are available in the US and EU.
CHMP rejects Kyowa Kirin’s Parkinson’s disease drug

We remain committed to pursuing the registration of istradefylline in the EU,” he added.
One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants

of AZ’s vaccine, named Vaxzevria in the EU, was 82% effective against hospitalisation or death caused by the Beta/Gamma variants.
Novartis sees demand returning to pre-COVID-19 levels in Q2 results

Its oncology business unit also grew by 4%, whiles its Sandoz generics unit posted a decrease of 5% in constant currencies due to the impact of COVID-19 in the EU. ... In the EU, inclisiran is already approved under the brand name Leqvio for the
EU approves bluebird bio’s CALD gene therapy Skysona

CALD is a progressive and fatal neurodegenerative disease that overwhelmingly affects males

More from news
Approximately 138 fully matching, plus 2,249 partially matching documents found.

Latest Intelligence

Pharma’s authentic proof of purpose influences decisions among HCPs and payers

Our research was conducted over several weeks in 2020 with over 2, 000 healthcare professionals across a wide range of therapy areas in the US and EU Big Five, as well
Piloting a route to the biosimilars opportunities in Europe

Investigating the EU regulatory hurdles that life sciences companies face as they seek to improve patient access to biosimilar therapy. ... By the end of 2020, it was estimated that biosimilars had saved the EU up to $44bn in healthcare costs.
EU cross-border healthcare

accessible information is established, to navigate the cross- border healthcare framework for all stakeholders (ie, a dedicated EU website). ... The development of Commission guidelines that set harmonised review and approval timelines that will expedite
From if to how: when imagination and regulation work together

For example, there are 30 million people in the EU who live with a rare disease, for whom the perceived lack of prioritisation is stark.
Rare genetic diseases – what’s in store for 2021?

EU integration. ... EU-funded research projects.

More from intelligence
Approximately 9 fully matching, plus 201 partially matching documents found.

Latest appointments

Ashfield Engage appoints Serap Becker as head of patient solutions in DACH region

Benjamin Rapp, regional president EU South at Ashfield Engage.
EFPIA confirms first and second vice-presidents

community to achieve the shared goal of building a future EU health and innovation union.”. ... Realising that goal means EFPIA and its membership working with the EU and Member States to build a world-class regulatory system, a strong and predictable
Hanover Health appoints Aleksandra Lugović as an associate director

Lugović joins from GOPA Com. Brussels, where she ran global campaigns for the European Commission across the EU, US, Africa and Asia. ... Prior to that, she headed the regional representation of South Serbia to the EU for a period of six years.
EFPIA appoints Hubertus von Baumbach as president

He added: “Over the coming months, my colleagues and I look forward to engaging with the EU Institutions and across Member States to discuss how we can work together to ensure ... that the EU remains an innovation leader and to build a healthier future
3 Monkeys Zeno taps Avril Lee to lead UK and EU healthcare business

Lee joins from The Red Consultancy. 3 Monkeys Zeno (3MZ) has appointed Avril Lee to the role of head of healthcare, UK and EU.

More from appointments
Approximately 2 fully matching, plus 67 partially matching documents found.

Latest from PMHub

Article

In her latest article for PME Magazine, Rachel Howard explores the implications for P&R decisions in EU countries following the FDA’s recent approval of Aduhelm as a treatment for
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development

doi:10.1136/bmj.n129. 24. Dean G, Reuters. The UK approved Pfizer’s vaccine too quickly and without the proper checks, EU politicians have warned.
Article:

Head of Living With, Mariel Metcalfe, discusses the market differences regarding the patient experience of those living with Crohn’s disease in the EU vs Japan, using data from Living With
Greener healthcare - a shared challenge

The potential for this thinking to permeate into other markets is strong – particularly with the Green Deal driving thinking across the EU –and could have wide ranging implications for access criteria
Aycan Hassan-Walker appointed as Regional Director, Europe of Nucleus Global

What is your vision for the Nucleus Global EU region? Digital transformation was already a focus for the pharmaceutical industry to improve, for instance, healthcare solutions, clinical trials, patient care,

More from PMHub
Approximately 3 fully matching, plus 129 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Digital Project Director, Healthcare Marketing Agency patient fo...: Highly competitive salary

Events Executive: Depending on Experience

Project Director, Healthcare Marketing Agency patient focus Lond...: Highly competitive salary

Group Account Director, Patient focussed account, Healthcare com...: circa £90K

Digital account director: Competitive

Account Manager - Healthcare Consultancy: Salary depending on experience

Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...: Highly competitive salary

Senior Consultant, Pricing & Market Access Consultancy, circ...: circa £100K package

Digital Engagement Strategist, Healthcare Brand Communications, ...: £75-90K

PMHub

Add my company

Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Guide: How to embrace behavioural science principles in healthcare MR...
Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand: The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started: Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...

Email:
Password:

Please login to the form below

EU

COVID-19 Updates and Daily News

Featured jobs

Quick links